Jefferies Maintains a 'Buy/Top Pick' on Valeant Pharmaceuticals (VRX); Taking the Right Medic(is)ine
Tweet Send to a Friend
Jefferies maintains a 'Buy' on Valeant Pharmaceuticals (NYSE: VRX) price target of $77.00 (from $63.00).
Analyst, Corey Davis, said ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Analyst, Corey Davis, said ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
